MENU

FIND DOCTORS

 

Name: Chen,Canming
Department: BREAST SURGERY
Title:Associate Professor

 
 
Education & Professional Experience   1999-2004. Cancer Hospital , Fudan University, School of Medicine (Former Shanghai Medical University) Ph.D. in Molecular Biology/Oncology
1990-1995 Shanghai Medical University M.D. Degree in Medicine
 
 
Specialty   Breast Surgery and Breast Reconstructive Surgery
 
 
Research   Neoadjuvant chemotherapy in breast cancer.
Studied the expression of Neu, Bax, ki-67, ER in breast cancer and its clinical predictive significance to the neoadjuvant chemotherapy. Responsible for immunohistochemistry,ELISA
Effect of neoadjuvant chemotherapy on the changing of biologic character in the LABC
Predictive factors for the effect of neoadjuvant chemotherapy of locally advanced breast cancer
Oophorectomy in the treatment of premenopausal metastatic breast cancer
Clinical research of very young breast cancer
The Diagnosis and treatment of early breast cancer
 
 
Publication   Huang O, Chen CM, Wu JY, et al. Retrospective analysis of 119 Chinese noninflammatory locally advanced breast cancer cases treated with intravenouscombination of vinorelbine and epirubicin as a neoadjuvant chemotherapy: a median follow-up of 63.4 months. BMC cancer, 2009 Oct 21,9: 375 (equal contributors)

Wu JY, Chen CM, Zhang JX,et al. Effect of postoperative pregnancy upon prognosis of young breast cancer patients. Natl Med J China, 2009 Dec 1, 89(44) (Corresponding author)

Huang O, Chen CM, Wu JY, et al . Study on predictors of long term results for neo-adjuvant chemotherapy in locally advanced breast cancer. Chinese Journal of Surgery. 2009, 47(7): 511-515

Ma CD, Chen CM, Chen XS,et al. Neoadjuvant chemotherapy with vinorelbine-containing regimens in elderly patients with locally advanced breast cancer。Anticancer Res. 2008 Sep-Oct; 28 (5B) :3093-7

Chen CM,Shen ZZ. The research status of predictive factors of neoadjuvant chemotherapy for breast cancer. The Journal of Evidence-based Medicine. 2007, 7(3): 132-134 (review)

Chen CM, Shen KW, Liu GY, Wu J, Lu JS, Zhuang CJ, Han QX, Liu BL, Shao ZM, Shen ZZ.
A study of the combination of vinorelbine and epirubicin as neoadjuvant chemotherapy regimen in the treatment of locally advanced breast cancer. Chinese Journal of Surgery. 2006 Jun 1;44(11):745-7

Liu GY, Chen CM, Hu Z, Ling H, Shen KW, Shen ZZ, Shao ZM. Stereotactic biopsy for non-palpable breast lesions: evaluation and choice of minimal invasive and excisional biopsy. Chinese Journal of Surgery. 2006 Oct 1;44(19):1322-4

Dong YB, Phelps AM, Yang HL, Jamshidi-Parsian A, Chen C, Hao H, Gomez-Gutierrez JG, Zhou HS, McMasters KM. Induction of apoptosis signal-regulating Kinase 1 by E2F-1 may not be essential for E2F-1-mediated apoptosis in melanoma cells. Tumour Biol. 2007;28(2):111-22. Epub 2007 Feb 8

Liu GY, Lu JS, Shen KW, Wu J, Chen CM, Hu Z, Shen ZZ, Zhang TQ, Shao ZM. Fiberoptic ductoscopy combined with cytology testing in the patients of spontaneous nipple discharge. Breast Cancer Res Treat. 2008 Mar;108(2):271-277. Epub 2007 May 2

Chen C.M., Shen K.W., Wu J., et al. PhaseⅡstudy of the combination of Vinorelbine and Epirubicin as neoadjuvant chemotherapy regimen in the treatment of locally advanced breast cancer. China Oncology , 2003, 13(4): 310-313

Chen C.M., Shen K.W., Shen Z.Z.. Systemic chemotherapy for the operable breast cancer. Chinese Journal of practical Clinical Medicine,2003,7(2):107-111(review)

Chen C.M., Shen K.W., Lu J.S., et al. The combination of vinorelbine and epirubicin as neoadjuvant chemotherapy regimen in the treatment of local advanced breast cancer. Proc Am Soc Clin Oncol 22: page 57, 2003 (abstr 228)

Chen C.M., Wu J., Shen K.W., et al. Vinorelbine and Adriamycin as neoadjuvant chemotherapy regimen for locally advanced breast cancer. Journal of Surgery Concepts & Practice 2001,6(4):226-228

Chen C.M., Shen Z.Z. Oncogene HER2 and breast cancer. China Oncology.2000,10(5):446-448 (review)

Chen C.M., Shao Z.M. Serum tumor DNA and breast cancer. Chinese Journal of practical Oncology,2000,15(5):555-557 (review)
 
 
Awards   N/A
 
 
Out-patient Schedule  

Tuesday afternoon, Wednesday morning